ERAS (STOCKS)
Erasca, Inc. Common Stock
$17.860000
-0.720000 (-3.88%)
Prev close: $18.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jonathan E. Lim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $6,505.86M
- Employees
- 129
- P/E (TTM)
- -19.46
- P/B (TTM)
- 16.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.60 | $-0.21 | -0.3869 | -181.56% |
|
Dec 2025 (Q4)
|
$-0.10 | $-0.11 | +0.0091 | +8.34% |
|
Sep 2025 (Q3)
|
$-0.11 | $-0.11 | -0.0046 | -4.36% |
|
Jun 2025 (Q2)
|
$-0.12 | $-0.11 | -0.0078 | -6.95% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $15.46M |
| Operating Expenses | $302.68M |
| Operating Income/Loss | -$302.68M |
| Income/Loss From Continuing Operations After Tax | -$287.22M |
| Income/Loss From Continuing Operations Before Tax | -$287.22M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$287.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$287.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$287.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.95 |
| Diluted Earnings Per Share | -$0.95 |
| Basic Average Shares | 591,627,716 |
| Diluted Average Shares | 591,627,716 |
| Assets | $435.05M |
| Current Assets | $278.44M |
| Cash | $384.30M |
| Noncurrent Assets | $156.61M |
| Fixed Assets | $11.92M |
| Other Non-current Assets | $144.70M |
| Liabilities | $73.19M |
| Current Liabilities | $33.57M |
| Accounts Payable | $2.02M |
| Other Current Liabilities | $31.55M |
| Noncurrent Liabilities | $39.61M |
| Equity | $361.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $361.87M |
| Liabilities And Equity | $435.05M |
| Net Cash Flow From Operating Activities | -$98.02M |
| Net Cash Flow From Operating Activities, Continuing | -$98.02M |
| Net Cash Flow From Investing Activities | -$173.92M |
| Net Cash Flow From Investing Activities, Continuing | -$173.92M |
| Net Cash Flow From Financing Activities | $248.34M |
| Net Cash Flow From Financing Activities, Continuing | $248.34M |
| Net Cash Flow | -$23.60M |
| Net Cash Flow, Continuing | -$23.60M |
| Comprehensive Income/Loss | -$287.56M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$288.89M |
| Other Comprehensive Income/Loss | -$75.03M |